1Alexander E, Moriarty T M, Davis R B, et al. Stereotactic radiosurgery for the definitive, non-invasive treatment of brain metastases [J]. J Natl Cancer Inst, 1995,87:34 - 40
2Arita T, Kuramitsu T, Kawamura M, et al. Bronchogenic carcinoma: Incidence of metastases to normal sized lymph nodes [J]. Thorax, 1995,50:1267 - 1269
3Bonomi P, Faber L: Neoadjuvant chemoradiation therapy in NSCLC: The Rush University experience [J]. Lung Cancer, 1993,9:383 - 390
4Burkes R, Ginsberg R, Shephard F, et al. Induction chemotherapy with mitomycin, vindesine and cisplatin for unresectable non-small cell lung cancer: Results of the Toronto phase Ⅱ trial [J]. J Clin Oncol, 1992,10:580 - 586
5Burt M, Wronski M, Galicich J, Martini N, Ginsberg R(Members of the Memorial Sloan-Kettering Cancer Center Thoracic and Neurosurgical Services). Solitary brain metastases from non-small cell lung cancer: Results of therapy. Presented at the 71st Annual Meeting of the American Association for Thoracic Surgery,Washington DC, May 6 - 8, 1991
6Chin R, Ward R, Keys J W. Mediastinal staging of non-small cell lung cancer with positron emission tomography [J]. Am J Respir Crit Care Med, 1995,152:2090 - 2096
7Decker D A, Diner D E, Pague W S, et al. The significance of a cytologically negative pleural effusion in bronchogenic carcinoma[J]. Chest, 1978,6: 640 - 642
8Dilleman B, Deneffe G, Verschakelen J, et al. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non small cell lung cancer [J]. EurJ Cadiothorac Surg, 1994,8:37 - 42
9Dillman R, Seagren S, Herndon J, et al. Randomized trial of induction chemotherapy plus reduction therapy vs. RT alone in stages Ⅲ NSCLC: Five-year follow-up of CALGB84-33 [J]. Proc Am Soc Clin Oncol, 1993, 12:329
10Dillman R, Seagren S, Prospert K, et al. A randomized trial of induction chemotherapy plus high-dose radiation vs. radiation alone in stage Ⅲ NSCLC[J]. N Engl J. Med,1990,323:940 -945
